本条目为第三方公开资料的归档,仅用于学术研究与科普,不构成任何操作指导或医学建议;物质处理涉及法律与健康风险,请在专业、合法的条件下自行核验。
正文中文为机器翻译,仅供参考;专业内容以折叠的原文为准。
- 详情
- 备注
这两种物质都会增强另一种物质引起的共济失调和镇静作用,高剂量时可能会导致意外的意识丧失。在失去知觉时,如果不处于恢复姿势,则有呕吐物误吸的风险。较高剂量的氯胺酮很可能会增加 DPH 的谵妄作用,并且会大大增加受伤、躁狂和精神病的风险。 Medical dosages of both substances are unlikely to cause concern.
查看原文
Both substances potentiate the ataxia and sedation caused by the other and can lead to unexpected loss of consciousness at high doses. While unconscious, vomit aspiration is a risk if not placed in the recovery position. Ketamine has a high likelihood of increasing DPH's deliriant effects at higher dosages and can greatly increase the risk of injury, mania, and psychosis. Medical dosages of both substances are unlikely to cause concern.
- 来源
- author
- Bylund, W., Delahanty, L., & Cooper, M.
- 标题
- The Case of Ketamine Allergy. Clinical Practice and Cases in Emergency Medicine, 1(4), 323–325. (2017)
- 链接
- https://doi.org/10.5811/cpcem.2017.7.34405
- author
- Clark, J. H., Meltzer, E. O., & Naclerio, R. M.
- 标题
- Diphenhydramine: It is time to say a final goodbye. World Allergy Organization Journal, 18(2), 101027. (2025)
- 链接
- https://doi.org/10.1016/j.waojou.2025.101027
- author
- Rosenbaum, S. B., Gupta, V., Patel, P., & Palacios, J. L.
- 标题
- Ketamine. In StatPearls. StatPearls Publishing. (2025)
- 链接
- http://www.ncbi.nlm.nih.gov/books/NBK470357/
- author
- Sicari, V., Patel, P., & Zabbo, C. P.
- 标题
- Diphenhydramine. In StatPearls. StatPearls Publishing. (2025)
- 链接
- http://www.ncbi.nlm.nih.gov/books/NBK526010/
- 风险等级
- 危险(应避免) (Dangerous)
- 物质 A
- 氯胺酮
- 物质 B
- diphenhydramine
来源与许可
TripSit · 药物资料
TripSit 数据规则:仅限非商业使用,需署名并在每个展示页附来源链接;组合数据仅为快速参考,需结合个体研究判断。
来源主页:https://wiki.tripsit.me/wiki/Factsheets
组合说明:https://wiki.tripsit.me/wiki/Drug_combinations